Interview with Russ Fadel, Augmentir

The value in applying AI in Pharma is in making new and better drugs available faster than would be possible otherwise. By augmenting sparse-data AI with expert knowledge...

Interview with Joachim Haupt and Florian Kaiser, PharmAI

Management pays a lot of attention to new ideas and cutting-edge technologies, but most of their resources are consumed by mature legacy technologies that are often not...

For many years, fine and specialty chemicals markets were on a robust growth path.

Interview with Jens Schmidt, ReCarbonX

Interview with Pedro Lopes, FastCompChem

What does 2022 hold for the biopharma industry? Which companies can play at the forefront in terms of products as well as business? Covid-19 will continue to be a...